Cite
Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry
MLA
Laakmann, E., et al. Long-Term Survival of HER2-Positive Breast Cancer Patients with Brain Metastases: Subanalysis of the BMBC Registry. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1383744968&authtype=sso&custid=ns315887.
APA
Laakmann, E., Riecke, K., Neunhoeffer, T., Park-Simon, T.-W., Weide, R., Polasik, A., Schmidt, M., Puppe, J., Fasching, P. A., Hesse, T., Decker, T., Denkert, C., Fehm, T. N., Nekljudova, V., Rey, J., Loibl, S., Mueller, V., & Witzel, I. (2022). Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry.
Chicago
Laakmann, E., K. Riecke, T. Neunhoeffer, T-W. Park-Simon, R. Weide, A. Polasik, M. Schmidt, et al. 2022. “Long-Term Survival of HER2-Positive Breast Cancer Patients with Brain Metastases: Subanalysis of the BMBC Registry.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1383744968&authtype=sso&custid=ns315887.